Davo
Agree the Surtek report will allow them to plot a clearer path so I look forward to hearing them state it. Your analysis is probably spot on, I simply worry about the cash balance. If they can hold off until grieve cashflow becomes available without a raising (I believe mid 2012) then those multiple millions for the chemical flood which will sweep the field anyway will be available.